Sveriges mest populära poddar
CME in Minutes: Education in Primary Care
Hälsa och motionMedicin

Rethinking HER2 Status: Practical Testing Considerations for HER2-Low and -Ultralow Advanced Breast Cancer

21 min•19 februari 2026
Please visit answersincme.com/CZS860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Giuseppe Curigliano, MD, PhD. In this activity, an expert in oncology discusses the differentiation of patients with HER2-low/ultralow/negative advanced breast cancer and treatment with antibody-drug conjugates. Upon completion of this activity, participants should be better able to: Differentiate HER2-low, -ultralow, and -negative advanced breast cancer; Identify patients with HER2-low and -ultralow advanced breast cancer who would benefit from treatment with antibody-drug conjugates; and Apply evidence-based strategies to connect testing to treatment in patients with HER2-low or -ultralow advanced breast cancer.

Fler avsnitt av CME in Minutes: Education in Primary Care

Visa alla avsnitt av CME in Minutes: Education in Primary Care
Guidance on Menopause-Related Vasomotor Symptom Management: A Focus on Neurokinin-Targeted Treatment Options
•27 min
Reducing Cardiometabolic Risk: What Cardiovascular Outcomes Trials Tell Us About Incretin-Based Therapies
•16 min
Advancing Secondary Stroke Prevention: How the Latest Evidence Informs Team-Based Practice
•1 tim 2 min
Early Defense: Answering Key Questions About the Science and Strategy of RSV Prevention in Infants
•20 min
Advancing Cardio-Kidney-Metabolic Care in Internal Medicine: Evidence-Based Guidance for Incorporating Nonsteroidal MRAs
•1 tim 8 min
Secondary Stroke Prevention Today and Tomorrow: Where Evolving Antithrombotic Strategies May Fit Into Hospitalist Care
•1 tim 1 min
Test, Treat, Repeat: Closing Persistent Gaps in HCV Care
•21 min
The Next Era of CKD Management in T1D: Evolving Care Strategies to Improve Patient Outcomes
•19 min
Taking the Long View on DME Management: Practical Approaches With Long-Acting Anti-VEGF Agents
•20 min
From Screening to Specialized Care: Navigating Key Questions in Alpha-1 Antitrypsin Deficiency–Associated Liver Disease
•16 min

CME in Minutes: Education in Primary Care med Answers in CME finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.